Shandong Teamgene Technology Co. Ltd. A (603151) — Capital Reinvestment Ratio
Shandong Teamgene Technology Co. Ltd. A (603151) has a Capital Reinvestment Ratio of 2.92x as of December 2022, meaning it reinvests 3% of its operating cash flow (CN¥59.07 Million) in capital expenditures (CN¥172.41 Million). See Shandong Teamgene Technology Co. Ltd. A (603151) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shandong Teamgene Technology Co. Ltd. A Capital Reinvestment Ratio (2020–2022)
This chart tracks Shandong Teamgene Technology Co. Ltd. A's Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for Shandong Teamgene Technology Co. Ltd. A (2020–2022)
Year-by-year Capital Reinvestment Ratio for Shandong Teamgene Technology Co. Ltd. A from 2020 to 2022. For live market cap and broader valuation context, see Shandong Teamgene Technology Co. Ltd. A (603151) total market value.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 2.92x | CN¥59.07 Million | CN¥172.41 Million | ▲ +294.4% |
| 2021 | 0.74x | CN¥131.51 Million | CN¥97.31 Million | ▲ +443.7% |
| 2020 | 0.14x | CN¥169.11 Million | CN¥23.02 Million | — |